sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastická činidla - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
sunitinib glenmark 12,5mg tvrdá tobolka
glenmark pharmaceuticals s.r.o., praha array - 17420 sunitinib - tvrdá tobolka - 12,5mg - sunitinib
sunitinib glenmark 25mg tvrdá tobolka
glenmark pharmaceuticals s.r.o., praha array - 17420 sunitinib - tvrdá tobolka - 25mg - sunitinib
sunitinib glenmark 50mg tvrdá tobolka
glenmark pharmaceuticals s.r.o., praha array - 17420 sunitinib - tvrdá tobolka - 50mg - sunitinib
sunitinib g.l. pharma 12,5mg tvrdá tobolka
g.l. pharma gmbh, lannach array - 17420 sunitinib - tvrdá tobolka - 12,5mg - sunitinib
sunitinib g.l. pharma 25mg tvrdá tobolka
g.l. pharma gmbh, lannach array - 17420 sunitinib - tvrdá tobolka - 25mg - sunitinib
sunitinib g.l. pharma 50mg tvrdá tobolka
g.l. pharma gmbh, lannach array - 17420 sunitinib - tvrdá tobolka - 50mg - sunitinib
sunitinib mylan 12,5mg tvrdá tobolka
mylan ireland limited, dublin array - 17420 sunitinib - tvrdá tobolka - 12,5mg - sunitinib
sunitinib mylan 25mg tvrdá tobolka
mylan ireland limited, dublin array - 17420 sunitinib - tvrdá tobolka - 25mg - sunitinib
sunitinib mylan 50mg tvrdá tobolka
mylan ireland limited, dublin array - 17420 sunitinib - tvrdá tobolka - 50mg - sunitinib